Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
BMC Gastroenterology
|
August 17, 2022
Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature review
Ke Cheng, Xia Liu, Ye Chen, et al.
Molecular Cancer Therapeutics
|
October 17, 2024
Pathogenesis and Systemic Treatment of Hepatocellular Carcinoma: Current Status and Prospects
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Molecular Biomedicine
|
January 9, 2025
Cancer vaccines: platforms and current progress
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Cancer Management and Research
|
December 19, 2019
Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer
Liangliang Bai, Pengfei Zhang, Kexun Zhou, et al.
NPJ Biofilms and Microbiomes
|
July 27, 2025
Gut microbiota shapes cancer immunotherapy responses
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 8, 2021
Atezolizumab and bevacizumab combination compared with sorafenib as the first-line systemic treatment for patients with unresectable hepatocellular carcinoma: A cost-effectiveness analysis in China and the United states
Feng Wen, Hanrui Zheng, Pengfei Zhang, et al.
Bioresource Technology
|
February 13, 2016
Using thermal balance model to determine optimal reactor volume and insulation material needed in a laboratory-scale composting reactor
Yongjiang Wang, Li Pang, Xinyu Liu, et al.
Oral Oncology
|
May 20, 2020
Pembrolizumab alone or with chemotherapy for squamous cell carcinoma of the head and neck: A cost-effectiveness analysis from Chinese perspective
Kexun Zhou, Yunzhu Li, Weiting Liao, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer
Kexun Zhou, Jing Zhou, Jiaxing Huang, et al.
Frontiers in Cell and Developmental Biology
|
March 4, 2022
Integratively Genomic Analysis Reveals the Prognostic and Immunological Characteristics of Pyroptosis and Ferroptosis in Pancreatic Cancer for Precision Immunotherapy
Ting Yu, Huaicheng Tan, Chunhua Liu, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
BMC Gastroenterology
|
August 17, 2022
Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature review
Ke Cheng, Xia Liu, Ye Chen, et al.
Molecular Cancer Therapeutics
|
October 17, 2024
Pathogenesis and Systemic Treatment of Hepatocellular Carcinoma: Current Status and Prospects
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Molecular Biomedicine
|
January 9, 2025
Cancer vaccines: platforms and current progress
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Cancer Management and Research
|
December 19, 2019
Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer
Liangliang Bai, Pengfei Zhang, Kexun Zhou, et al.
NPJ Biofilms and Microbiomes
|
July 27, 2025
Gut microbiota shapes cancer immunotherapy responses
Wanting Lei, Kexun Zhou, Ye Lei, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 8, 2021
Atezolizumab and bevacizumab combination compared with sorafenib as the first-line systemic treatment for patients with unresectable hepatocellular carcinoma: A cost-effectiveness analysis in China and the United states
Feng Wen, Hanrui Zheng, Pengfei Zhang, et al.
Bioresource Technology
|
February 13, 2016
Using thermal balance model to determine optimal reactor volume and insulation material needed in a laboratory-scale composting reactor
Yongjiang Wang, Li Pang, Xinyu Liu, et al.
Oral Oncology
|
May 20, 2020
Pembrolizumab alone or with chemotherapy for squamous cell carcinoma of the head and neck: A cost-effectiveness analysis from Chinese perspective
Kexun Zhou, Yunzhu Li, Weiting Liao, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 20, 2019
Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer
Kexun Zhou, Jing Zhou, Jiaxing Huang, et al.
Frontiers in Cell and Developmental Biology
|
March 4, 2022
Integratively Genomic Analysis Reveals the Prognostic and Immunological Characteristics of Pyroptosis and Ferroptosis in Pancreatic Cancer for Precision Immunotherapy
Ting Yu, Huaicheng Tan, Chunhua Liu, et al.
Page
of 4